Dr. Gerard Criner to Serve as Lead Principal Investigator for Clinical Study Examining New Treatment for Patients with COPD and Chronic Bronchitis

Gerard J. Criner, MD, FACP, FACCP, Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine at Temple University and Director of the Temple Lung Center, will be the lead principal investigator for a clinical study examining the RejuvenAir System, a metered cryospray of liquid nitrogen targeted to certain areas in the lungs for patients with moderate to severe COPD with chronic bronchitis. The RejuvenAir System has been designated a breakthrough device by the U.S. Food and Drug Administration and has received unconditional investigational device exemption approval for a trial across 30 sites in the U.S., Europe and Canada with up to 330 subjects. Markets Insider, Marketplace, the Pittsburgh Post-Gazette, WBOC-TV and others covered the announcement.